Related Experiment Videos
Recent advances in continuous renal replacement therapy: citrate anticoagulated continuous arteriovenous hemodialysis
Insights
Trisodium citrate regional anticoagulation effectively replaces systemic heparinization in continuous arteriovenous hemodialysis (CAVHD). This citrate-based method offers comparable efficacy while avoiding heparin-associated complications in critically ill patients.
Area of Science:
- Nephrology
- Critical Care Medicine
- Pharmacology
Background:
- Continuous arteriovenous hemodialysis (CAVHD) often requires systemic anticoagulation, typically with heparin.
- Heparin use in critically ill uremic patients can lead to complications.
- Alternative anticoagulation strategies are needed to improve patient safety.
Purpose of the Study:
- To evaluate the efficacy and safety of trisodium citrate as a regional anticoagulant in CAVHD.
- To compare citrate anticoagulation with traditional heparin anticoagulation in CAVHD.
- To assess the impact of citrate on CAVHD parameters and patient outcomes.
Main Methods:
- Trisodium citrate was administered as a regional anticoagulant to 24 patients undergoing CAVHD.
- Systemic heparinization was avoided.
- Key parameters including clearances, blood flow rate, ultrafiltration, and filter patency were monitored and compared to historical heparinized CAVHD data.
Main Results:
- CAVHD with trisodium citrate demonstrated favorable clearances, blood flow rates, ultrafiltration, and filter patency.
- The need for systemic heparinization was eliminated.
- No significant heparin-associated complications were observed in the citrate anticoagulated group.
Conclusions:
- Trisodium citrate serves as an effective regional anticoagulant for CAVHD.
- Citrate anticoagulation provides comparable or superior outcomes to heparin while mitigating heparin-related risks.
- This approach enhances the safety profile of CAVHD for critically ill uremic patients.
Abstract:
Trisodium citrate was used as a regional anticoagulant on 24 patients on continuous arteriovenous hemodialysis (CAVHD), obviating the need for systemic heparinization. Principles of CAVHD, potential complications, and nursing responsibilities are addressed. Clearances, blood flow rate, ultrafiltration and filter patency compare favorably with heparin CAVHD. Citrate anticoagulated CAVHD avoids heparin-associated complications in the critically ill uremic patient.